Rudolph Nisi, Director at Galena Biopharma, Inc. (GALE), sold 500 shares at $0.55 ($275) on 2017-06-20, disclosed to the SEC on 2017-06-22.
Open-market sale of $275 GALE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| GALE | SELL | 2014-01-22 | $1.4M | — | Filing → |